INNOCIMAB PTE. LTD.
Last Updated: 13 Apr 2026
Innokeys is a biopharmaceutical company founded in 2012 by experienced industry professionals Johannes Setijono and Rikrik Ilyas. Our mission is to provide value-added innovations in biopharmaceuticals and become a global player with significant contributions to unmet medical needs. We adopt innovative approaches and strive for excellence, while being agile and adaptable to overcome uncertainties. Our product websites include nimotuzumab.com, theracim.com, and innogene-kalbiotech.com, among others. We have partnerships with leading companies such as Daiichi Sankyo (Japan), Kuhnil Pharmaceuticals (Korea), and Oncoscience AG (Europe).
Country of registration | Singapore |
Registration number | 201428922D |
Local SIC | |
Incorporation date | 29 Sep 2014 |
Company age | 11 years 8 months |
Official entity type | Private Limited Company |
No. of officers | 13 |
Contact
Address:
205 BALESTIER ROAD, #02-06, THE MEZZO, Singapore 329682
Access Key Decision Makers
This is the legal entity page of INNOCIMAB PTE. LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.
Associated business (1)
- INNOKEYS PTE LTDView MoreSingaporeInnokeys is a biopharmaceutical company founded in 2012 by experienced industry professionals Johannes Setijono and Rikrik Ilyas. Our mission is to provide value-added innovations in biopharmaceuticals and become a global player with significant contributions to unmet medical needs. We adopt innovative approaches and strive for excellence, while being agile and adaptable to overcome uncertainties. Our product websites include nimotuzumab.com, theracim.com, and innogene-kalbiotech.com, among others. We have partnerships with leading companies such as Daiichi Sankyo (Japan), Kuhnil Pharmaceuticals (Korea), and Oncoscience AG (Europe).
This is the legal entity page of INNOCIMAB PTE. LTD.. To access company info, company size, news, key maker's emails, visit the profile pages above.
Financials
Fiscal/Budgeting Period | October - December |
Auditor | CPA LINK |
Revenue | 1m - 5m |
Financial period end date | 31 Dec 2020 |
Share Capital - Ordinary shares | USD 100 |
Last updated: 13 Apr 2026
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Discover More Companies
Lookalike companies
* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.
Frequently Asked Questions (FAQ)
- What is the address of INNOCIMAB PTE. LTD.?
- Where is INNOCIMAB PTE. LTD.'s headquarter?
- What is INNOCIMAB PTE. LTD.'s contact number?
- What INNOCIMAB PTE. LTD.'s spending power?
- Does INNOCIMAB PTE. LTD. have a presence in the domain it operates in?